A vaccination center in Hod Hasharon, Israel, on February 2, 2021. (Miriam Alster/Flash90)
Vaccinated people become far less of a COVID transmission risk even before receiving their second dose, a new “game-changing” Israeli study has concluded.
The first mass research of its kind on patients who test positive for the coronavirus and are confirmed to have been at least partially vaccinated, the study found that such patients have far smaller viral loads than those who haven’t received the vaccine.
“Our results show that infections occurring 12 days or longer following vaccination have significantly reduced viral loads,” wrote a multi-institution research team that crunched data from the Maccabi healthcare provider, stating they believe that could be important in “potentially affecting viral shedding and contagiousness as well as severity of the disease.”
Dive Brief:
Israeli cell-based meat producer Aleph Farms and biomedical engineering researchers at the Technion-Israel Institute of Technology announced they have created the world s first slaughter-free ribeye steak through cell cultivation and 3D bioprinting.
Aleph Farms 3D bioprinting technology combines cell cultivation and 3D printing. Living cells are printed into a shape, and are then incubated to grow, interact and differentiate, allowing the cell-based meat to take on more of the characteristics of a conventional steak, according to the company.
The cell-based meat industry has recently made several technical and regulatory strides that bring it closer to becoming a common product on the marketplace. In December, U.S.-based Eat Just announced it had received regulatory approval in Singapore for cell-based chicken bites to be sold at a restaurant.
Pfizer vaccinees less likely to pass coronavirus to others
Findings indicate vaccination cuts risk of infecting others, reducing viral load by 1.6 to 20 times in vaccinated individuals who are Covid positive.
February 9, 2021, 9:51 am
An Israeli woman receives a Pfizer-BioNtech Covid-19 vaccine on February 7, 2021, in Hadera. Photo by Gili Yaari/Flash90
People who’ve received the Pfizer-BioNTech vaccination against Covid-19 seem significantly less likely to “shed” or transmit virus particles that may be in their nose or throat.
That is the finding of a study pre-published on February 8 by Israeli scientists from Covid testing centers MyHeritage Lab and the Central Virology Laboratory at Sheba Medical Center.
Technion to award Pfizer CEO honorary doctorate jewishledger.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishledger.com Daily Mail and Mail on Sunday newspapers.